Literature DB >> 8005970

Prognosis and management of membraneous nephropathy.

D K Pahari1, S Das, B N Dutta, D Banerjee.   

Abstract

Patients of idiopathic membranous nephropathy (MGN) were randomly assigned to received steroid and cyclophosphamide every other month (Gr-I) and steroid alone (Gr-II). Of 36 patients in Gr.I, 33 patients achieved complete remissions, 2 had relapsing course with remission on further courses of therapy and only one has reached end stage renal failure. In contrast, of the 35 patients in Gr. II, 15 (P < 0.001) achieved complete remission, 7 are in partial remission, 5 have no response, another 5 have deterioration of renal function of which two required dialysis, and 3 have relapsing course after the initial remission. Mean follow up period was 46 +/- 10.2 months. We conclude that steroid and cyclophosphamide every other month is highly effective in achieving remission in patients with membranous nephropathy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8005970

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN: 0004-5772


  5 in total

Review 1.  Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.

Authors:  Thilo C von Groote; Gabrielle Williams; Eric H Au; Yizhi Chen; Anna T Mathew; Elisabeth M Hodson; David J Tunnicliffe
Journal:  Cochrane Database Syst Rev       Date:  2021-11-15

Review 2.  Immunosuppression for membranous nephropathy: a systematic review and meta-analysis of 36 clinical trials.

Authors:  Yizhi Chen; Arrigo Schieppati; Guangyan Cai; Xiangmei Chen; Javier Zamora; Giovanni A Giuliano; Norbert Braun; Annalisa Perna
Journal:  Clin J Am Soc Nephrol       Date:  2013-02-28       Impact factor: 8.237

Review 3.  Idiopathic membranous nephropathy: management strategies.

Authors:  Marco Quaglia; Piero Stratta
Journal:  Drugs       Date:  2009-07-09       Impact factor: 9.546

4.  Immunosuppression therapy for idiopathic membranous nephropathy: systematic review with network meta-analysis.

Authors:  Bhadran Bose; Edmund Y M Chung; Regina Hong; Giovanni F M Strippoli; David W Johnson; Wen-Ling Yang; Sunil V Badve; Suetonia C Palmer
Journal:  J Nephrol       Date:  2022-02-23       Impact factor: 4.393

5.  Comparative effectiveness and tolerance of immunosuppressive treatments for idiopathic membranous nephropathy: A network meta-analysis.

Authors:  Song Ren; Ying Wang; Li Xian; Tadashi Toyama; Meg Jardine; Guisen Li; Vlado Perkovic; Daqing Hong
Journal:  PLoS One       Date:  2017-09-12       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.